FDA Approved: MIFEPRISTONE — Supplemental Application (Corcept Therapeutics Incorporated)

View source ↗

Summary

The FDA approved a supplemental application for mifepristone from Corcept Therapeutics, updating the drug's labeling/indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endogenous Cushing Syndrome

Drugs mentioned

• Korlym (mifepristone)

Snippet

SUPPL AP for MIFEPRISTONE (MIFEPRISTONE)